Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1983
Effect of phenytoin on proliferation and differentiation of mouse muscle cells in vitroS GoyleTeratogenesis, Carcinogenesis, and Mutagenesis|May 13, 1999
Genotoxicity of the anticonvulsant drug phenytoin (PHT): a follow-up study of PHT-untreated epileptic patients. II. Mitotic index (MI) and proliferation kineticsA Kaul, S GoyleTeratogenesis, Carcinogenesis, and Mutagenesis|May 13, 1999
Genotoxicity of the anticonvulsant drug phenytoin (PHT): a follow-up study of PHT-untreated epileptic patients. I. Sister chromatid exchange (SCE) analysisA Kaul, S GoyleMethods and Findings in Experimental and Clinical Pharmacology|March 1, 1985
Mutagenic potential of anticonvulsant diphyenylhydantoin (DPH) on human lymphocytes in vitroA K Maurya, S GoyleNeurology India|February 7, 2001
Detection of deletion in the dystrophin gene of a patient with quadriceps myopathyD Kumari, M Gupta, S GoyleBiochemical Medicine|October 1, 1983
Altered lipid composition of adipose tissue in human muscular dystrophyA K Banerjee, S GoyleTeratogenesis, Carcinogenesis, and Mutagenesis|February 27, 2001
I. The modulatory effect in genotoxic responses due to age and duration of PHT-therapy in epileptic patientsA Kaul, N R Kalla, S GoyleTeratogenesis, Carcinogenesis, and Mutagenesis|February 27, 2001
II. An altered proliferation response due to the anticonvulsant phenytoin (PHT) in epileptic patientsA Kaul, N R Kalla, S GoyleJournal of the Neurological Sciences|June 10, 1998
Molecular characterisation of Duchenne muscular dystrophy and phenotypic correlationA Mital, D Kumari, M Gupta, et al.Neurology India|April 17, 2001
Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspectsV Handa, A Mital, M Gupta, et al.Pageof 4